Evidence map›Paper›PMID 26622192›Full record

ReviewInternational journal of women's health2015

Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy.

Krisztina Fischer, Nathan J McDannold, Clare M Tempany, Ferenc A Jolesz, Fiona M Fennessy

Abstract readReview
In one paragraph

Review in International journal of women's health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Abnormal uterine bleeding successfully treatedWorld journal of clinical cases · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Krisztina FischerDepartment of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ; Renal Division, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ; Biomedical Engineering Division, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Nathan J McDannoldDepartment of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Clare M TempanyDepartment of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Ferenc A JoleszDepartment of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Fiona M FennessyDepartment of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ; Department of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Funding

Multidisciplinary Training in Image-Guided TherapyR25CA089017 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI FENNESSY, FIONA · 2001 to 2017
$7.8M
NCI NIH HHS R25 CA089017
6 · The paper itself

Abstract

Minimally invasive treatment options are an important part of the uterine fibroid-treatment arsenal, especially among younger patients and in those who plan future pregnancies. This article provides an overview of the currently available minimally invasive therapy options, with a special emphasis on a completely noninvasive option: magnetic resonance-guided focused ultrasound (MRgFUS). In this review, we describe the background of MRgFUS, the patient-selection criteria for MRgFUS, and how the procedure is performed. We summarize the published clinical trial results, and review the literature on pregnancy post-MRgFUS and on the cost-effectiveness of MRgFUS.

Indexed as

focused ultrasoundminimally invasive treatmentMRgFUSuterine fibroids

Identifiers

PMID26622192
PMCPMC4654554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.